Hans L. Tillmann

Gastroenterology

2100 Stantonsburg Rd
Greenville, NC 27834

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Letter: Using Anti-HBs Titers to Tailor HBV Reactivation Monitoring in Patients With Solid Tumours-Authors' Reply.

Letter: Using Anti-HBs Titers to Tailor HBV Reactivation Monitoring in Patients With Solid Tumours-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: January 10, 2026

Finite Treatments for Viral Hepatitis : Is "Sustained Control" Versus Cure Acceptable for HBV?

Finite Treatments for Viral Hepatitis : Is "Sustained Control" Versus Cure Acceptable for HBV?

Journal: The American journal of gastroenterology

Published: July 29, 2025

Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.

Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.

Journal: Drug safety

Published: May 27, 2025

Meta-Analysis: High anti-HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment.

Meta-Analysis: High anti-HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment.

Journal: Alimentary pharmacology & therapeutics

Published: May 25, 2025

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.

Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury.

Journal: Drug safety

Published: September 01, 2024

Liver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests.

Liver toxicity in oncology trials and beyond: a simplified concept for management of hepatocellular drug-induced liver injury in patients with abnormal baseline liver tests.

Journal: Expert opinion on drug safety

Published: March 14, 2024

Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.

Review article: Recommendations for detection, assessment and management of suspected drug-induced liver injury during clinical trials in oncology patients.

Journal: Alimentary pharmacology & therapeutics

Published: March 13, 2024

Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice.

Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice.

Journal: Journal of personalized medicine

Published: December 01, 2023

Trends in mortality from gastrointestinal, hepatic, and pancreatic cancers in the United States: A comprehensive analysis (1999-2020).

Trends in mortality from gastrointestinal, hepatic, and pancreatic cancers in the United States: A comprehensive analysis (1999-2020).

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: October 04, 2023

Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy.

Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy.

Journal: Digestive diseases and sciences

Published: June 09, 2023

Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration.

Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration.

Journal: Drug safety

Published: November 06, 2022

It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B.

It's not all about the virus-On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B.

Journal: Hepatology (Baltimore, Md.)

Published: September 11, 2022

Showing 1-12 of 77

Last Updated: 09/26/2026